1. Home
  2. BNGO vs ICCC Comparison

BNGO vs ICCC Comparison

Compare BNGO & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNGO
  • ICCC
  • Stock Information
  • Founded
  • BNGO 2003
  • ICCC 1982
  • Country
  • BNGO United States
  • ICCC United States
  • Employees
  • BNGO N/A
  • ICCC N/A
  • Industry
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNGO Industrials
  • ICCC Health Care
  • Exchange
  • BNGO Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • BNGO 28.7M
  • ICCC 28.0M
  • IPO Year
  • BNGO 2018
  • ICCC 1987
  • Fundamental
  • Price
  • BNGO $0.21
  • ICCC $3.66
  • Analyst Decision
  • BNGO Hold
  • ICCC
  • Analyst Count
  • BNGO 3
  • ICCC 0
  • Target Price
  • BNGO $1.00
  • ICCC N/A
  • AVG Volume (30 Days)
  • BNGO 3.5M
  • ICCC 14.5K
  • Earning Date
  • BNGO 11-13-2024
  • ICCC 11-13-2024
  • Dividend Yield
  • BNGO N/A
  • ICCC N/A
  • EPS Growth
  • BNGO N/A
  • ICCC N/A
  • EPS
  • BNGO N/A
  • ICCC N/A
  • Revenue
  • BNGO $33,334,000.00
  • ICCC $23,838,002.00
  • Revenue This Year
  • BNGO N/A
  • ICCC N/A
  • Revenue Next Year
  • BNGO $21.35
  • ICCC N/A
  • P/E Ratio
  • BNGO N/A
  • ICCC N/A
  • Revenue Growth
  • BNGO N/A
  • ICCC 46.37
  • 52 Week Low
  • BNGO $0.20
  • ICCC $3.34
  • 52 Week High
  • BNGO $2.27
  • ICCC $5.59
  • Technical
  • Relative Strength Index (RSI)
  • BNGO 24.89
  • ICCC 54.28
  • Support Level
  • BNGO $0.27
  • ICCC $3.40
  • Resistance Level
  • BNGO $0.38
  • ICCC $3.64
  • Average True Range (ATR)
  • BNGO 0.02
  • ICCC 0.16
  • MACD
  • BNGO -0.00
  • ICCC 0.01
  • Stochastic Oscillator
  • BNGO 0.00
  • ICCC 65.12

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: